Trupanion (TRUP) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary

Inflationary dynamics and margin management

• Veterinary inflation has remained elevated at 15% for 2023 and 2024, prompting significant rate increases to maintain margins.

• Over 25% rate increases have flowed through the book for 24 consecutive months, with margin expansion now visible in Q2 results.

• Sufficient rate is in place for 2024, and future rate needs are expected to be below the 20% threshold.

• Retention rates remain strong despite higher costs, supported by direct vet payments and product stickiness.

• Pet acquisition spend will gradually increase as margin strength is restored, especially in high-ROI channels.

Regulatory and capital developments

• NAIC classified pet insurance as its own P&C line, doubling surplus capital to over $130 million.

• Surplus now stands at 2x the minimum requirement, providing flexibility for investment and growth.

• Capital freed up by rolling off a capital-intensive business segment will support further expansion.

• Each investment is evaluated using a 30%-40% IRR framework to ensure disciplined capital allocation.

Geographic and product expansion

• California received a 40% rate increase approval, enabling renewed pet acquisition efforts in the state.

• Rate approval cadence in California is shifting to more frequent, smaller adjustments, improving pricing consistency.

• Non-core products like PHI Direct and Furkin are small but positioned for future growth, with scaling expected in 24-36 months.

• International expansion is underway, with gradual rollouts in Europe and plans for vertical integration via local licenses.